Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

I found that so many people were making their own GLP-1s and taking smaller amounts than normally prescribed,” she said. “I ...

People have been showing off their before-and-after when taking Ozempic and other weight-loss drugs ... "It's studies like this that we hope will definitely move the needle on (insurance) coverage." ...

Ozempic manufacturer Novo Nordisk said patient safety is a priority and “the benefit-risk profile of semaglutide remains unchanged” Ricardo Rubio/Europa Press via Getty Health officials in ...